OPTN Insider Trading
Insider Ownership Percentage: 2.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $261,223.65
OptiNose Share Price & Price History
Current Price: $9.14
Price Change: ▼ Price Decrease of -0.03 (-0.33%)
As of 04/1/2025 03:11 PM ET
OptiNose Insider Trading History
OptiNose Institutional Trading History
Data available starting January 2016
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania.
Read More on OptiNose
Volume
90,263 shs
Average Volume
63,262 shs
Market Capitalization
$91.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of OptiNose?
Who are the major institutional investors of OptiNose?
OptiNose's top institutional shareholders include:
- Nantahala Capital Management LLC — 9.80%
- MVM Partners LLC — 9.68%
- Rosalind Advisors Inc. — 8.72%
- Stonepine Capital Management LLC — 5.85%
- Acorn Capital Advisors LLC — 4.20%
- D. E. Shaw & Co. Inc. — 3.31%
Learn More about top institutional investors of OptiNose stock.
Which major investors are selling OptiNose stock?
During the previous quarter, OPTN stock was sold by these institutional investors:
- MVM Partners LLC
- Nantahala Capital Management LLC
- Rosalind Advisors Inc.
- Stonepine Capital Management LLC
- D. E. Shaw & Co. Inc.
- Bleichroeder LP
- Easterly Investment Partners LLC
- Geode Capital Management LLC
During the previous year, company insiders that have sold OptiNose company stock include:
- Ramy A Mahmoud (CEO)
- Michael F Marino III (Insider)
- Paul Jr Spence (Insider)
- Anthony J Krick (CAO)
Learn More investors selling OptiNose stock.
Which major investors are buying OptiNose stock?
During the last quarter, OPTN stock was purchased by institutional investors including:
- Acorn Capital Advisors LLC